These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31411909)

  • 1. Non-antibiotic therapy for
    Yang J; Yang H
    Crit Rev Clin Lab Sci; 2019 Nov; 56(7):493-509. PubMed ID: 31411909
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term durability and safety of fecal microbiota transplantation for recurrent or refractory Clostridioides difficile infection with or without antibiotic exposure.
    Lee CH; Chai J; Hammond K; Jeon SR; Patel Y; Goldeh C; Kim P
    Eur J Clin Microbiol Infect Dis; 2019 Sep; 38(9):1731-1735. PubMed ID: 31165961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Clostridium difficile Infection with Systemic Antimicrobial Therapy Following Successful Fecal Microbiota Transplant: Should We Recommend Anti-Clostridium difficile Antibiotic Prophylaxis?
    Allegretti JR; Kao D; Phelps E; Roach B; Smith J; Ganapini VC; Kassam Z; Xu H; Fischer M
    Dig Dis Sci; 2019 Jun; 64(6):1668-1671. PubMed ID: 30632052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on Treatment of Clostridioides difficile Infection.
    Cho JM; Pardi DS; Khanna S
    Mayo Clin Proc; 2020 Apr; 95(4):758-769. PubMed ID: 32247350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal microbiota transplantation (FMT) for C. difficile infection, just say 'No'.
    Tan X; Johnson S
    Anaerobe; 2019 Dec; 60():102092. PubMed ID: 31472233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiota-based Therapies Clostridioides difficile infection that is refractory to antibiotic therapy.
    Mehta SR; Yen EF
    Transl Res; 2021 Apr; 230():197-207. PubMed ID: 33278650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of Bloodstream Infections, Length of Hospital Stay, and Survival in Patients With Recurrent Clostridioides difficile Infection Treated With Fecal Microbiota Transplantation or Antibiotics: A Prospective Cohort Study.
    Ianiro G; Murri R; Sciumè GD; Impagnatiello M; Masucci L; Ford AC; Law GR; Tilg H; Sanguinetti M; Cauda R; Gasbarrini A; Fantoni M; Cammarota G
    Ann Intern Med; 2019 Nov; 171(10):695-702. PubMed ID: 31683278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current and future trends in clostridioides (clostridium) difficile infection management.
    Khanna S; Gerding DN
    Anaerobe; 2019 Aug; 58():95-102. PubMed ID: 31054313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update of treatment algorithms for Clostridium difficile infection.
    Ooijevaar RE; van Beurden YH; Terveer EM; Goorhuis A; Bauer MP; Keller JJ; Mulder CJJ; Kuijper EJ
    Clin Microbiol Infect; 2018 May; 24(5):452-462. PubMed ID: 29309934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention and treatment of recurrent Clostridioides difficile infection.
    Shin JH; Warren CA
    Curr Opin Infect Dis; 2019 Oct; 32(5):482-489. PubMed ID: 31369420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridioides difficile: Current overview and future perspectives.
    Giles J; Roberts A
    Adv Protein Chem Struct Biol; 2022; 129():215-245. PubMed ID: 35305720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to: prophylactic interventions for prevention of Clostridioides difficile infection.
    Reigadas E; van Prehn J; Falcone M; Fitzpatrick F; Vehreschild MJGT; Kuijper EJ; Bouza E;
    Clin Microbiol Infect; 2021 Dec; 27(12):1777-1783. PubMed ID: 34245901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clostridium difficile infection: A brief update on emerging therapies.
    Goldberg EJ; Bhalodia S; Jacob S; Patel H; Trinh KV; Varghese B; Yang J; Young SR; Raffa RB
    Am J Health Syst Pharm; 2015 Jun; 72(12):1007-12. PubMed ID: 26025991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frontiers in antibiotic alternatives for
    Phanchana M; Harnvoravongchai P; Wongkuna S; Phetruen T; Phothichaisri W; Panturat S; Pipatthana M; Charoensutthivarakul S; Chankhamhaengdecha S; Janvilisri T
    World J Gastroenterol; 2021 Nov; 27(42):7210-7232. PubMed ID: 34876784
    [No Abstract]   [Full Text] [Related]  

  • 15. Probiotics for prevention of Clostridium difficile infection.
    Mills JP; Rao K; Young VB
    Curr Opin Gastroenterol; 2018 Jan; 34(1):3-10. PubMed ID: 29189354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Faecal microbiota transplantation plus selected use of vancomycin for severe-complicated Clostridium difficile infection: description of a protocol with high success rate.
    Fischer M; Sipe BW; Rogers NA; Cook GK; Robb BW; Vuppalanchi R; Rex DK
    Aliment Pharmacol Ther; 2015 Aug; 42(4):470-6. PubMed ID: 26096320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probiotics: insights and new opportunities for
    Pal R; Athamneh AIM; Deshpande R; Ramirez JAR; Adu KT; Muthuirulan P; Pawar S; Biazzo M; Apidianakis Y; Sundekilde UK; de la Fuente-Nunez C; Martens MG; Tegos GP; Seleem MN
    Crit Rev Microbiol; 2023 May; 49(3):414-434. PubMed ID: 35574602
    [No Abstract]   [Full Text] [Related]  

  • 18. Fecal microbiota transplantation for the treatment of Clostridium difficile infection.
    Rao K; Safdar N
    J Hosp Med; 2016 Jan; 11(1):56-61. PubMed ID: 26344412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
    Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
    Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Individualized treatment strategies for Clostridium difficile infections].
    Solbach P; Dersch P; Bachmann O
    Internist (Berl); 2017 Jul; 58(7):675-681. PubMed ID: 28589214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.